IS4057A - Efni til að auka kyngetu - Google Patents

Efni til að auka kyngetu

Info

Publication number
IS4057A
IS4057A IS4057A IS4057A IS4057A IS 4057 A IS4057 A IS 4057A IS 4057 A IS4057 A IS 4057A IS 4057 A IS4057 A IS 4057A IS 4057 A IS4057 A IS 4057A
Authority
IS
Iceland
Prior art keywords
pct
eggs
sec
date
pub
Prior art date
Application number
IS4057A
Other languages
English (en)
Inventor
Eskeland Bjødne
Gjendemsjø Peder
Original Assignee
Matforsk, Norwegian Food Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO922988A external-priority patent/NO302335B1/no
Priority claimed from GB939314335A external-priority patent/GB9314335D0/en
Application filed by Matforsk, Norwegian Food Research Institute filed Critical Matforsk, Norwegian Food Research Institute
Publication of IS4057A publication Critical patent/IS4057A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Insulated Conductors (AREA)
  • Golf Clubs (AREA)
  • Inorganic Insulating Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS4057A 1992-07-29 1993-07-26 Efni til að auka kyngetu IS4057A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO922988A NO302335B1 (no) 1992-07-29 1992-07-29 Potensfremmende middel og fremstilling derav
GB939314335A GB9314335D0 (en) 1993-07-08 1993-07-08 Composition

Publications (1)

Publication Number Publication Date
IS4057A true IS4057A (is) 1994-01-30

Family

ID=26303227

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4057A IS4057A (is) 1992-07-29 1993-07-26 Efni til að auka kyngetu

Country Status (13)

Country Link
US (1) US5641517A (is)
EP (1) EP0656781B1 (is)
JP (1) JP3065353B2 (is)
KR (1) KR100277095B1 (is)
CN (1) CN1100545C (is)
AT (1) ATE188609T1 (is)
AU (1) AU4715093A (is)
CA (1) CA2141197A1 (is)
DE (1) DE69327585T2 (is)
FI (1) FI950369A0 (is)
IS (1) IS4057A (is)
NZ (1) NZ254859A (is)
WO (1) WO1994003192A1 (is)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO303819B1 (no) * 1996-11-20 1998-09-07 Drymed As Anvendelse av t°rkede, fertiliserte h°nse-egg for fremstilling av anti-depressive midler
EP1363510B1 (en) * 2001-03-02 2007-05-16 Kalsec, Incorporated Labiatae herb extracts and hop extracts for extending the color life and inhibiting the growth of microorganisms in fresh meat, fish and poultry
AU2008243262B2 (en) * 2001-06-20 2012-01-19 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7666449B2 (en) * 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US20040115290A1 (en) * 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
KR20050071605A (ko) * 2002-10-21 2005-07-07 메타프로테오믹스, 엘엘씨 염증반응과 관련된 병리학적 상태를 치료하거나 저해하는조성물
WO2005039483A2 (en) * 2003-05-22 2005-05-06 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
CN1332646C (zh) * 2003-10-08 2007-08-22 张洪庭 一种治疗白发脱发排毒的洗发膏
WO2005089104A2 (en) * 2004-02-23 2005-09-29 Segal, Janet Feeds containing hop acids and uses thereof as supplements in animal feeds
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
AU2005304317A1 (en) * 2004-11-13 2006-05-18 Metaproteomics, Llc Compositions exhibiting inhibition of cyclooxygenase-2
MX2008001903A (es) * 2005-08-09 2008-04-16 Metaproteomics Llc Modulacion de proteina cinasa por medio de lupulos y productos de acacia.
NZ568860A (en) * 2005-12-09 2012-09-28 Metaproteomics Llc Protein kinase modulation by hops and acacia products
US10835576B2 (en) * 2006-05-18 2020-11-17 Myos Rens Technology Inc. Method of obtaining effective amounts of avian follistatin
US20070275036A1 (en) 2006-05-18 2007-11-29 Celldyne Biopharma, Llc Avian follistatin product
JP2009541325A (ja) * 2006-06-20 2009-11-26 メタプロテオミクス， エルエルシー テトラヒドロ−イソアルファ酸に基づくタンパク質キナーゼ調節癌治療
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
CN101583368B (zh) * 2006-10-12 2015-07-15 统一帕拉贡联合有限公司 制备受精卵组分的方法
NZ579340A (en) * 2007-03-19 2012-05-25 Metaproteomics Llc Methods and compositions for promoting bone and joint health comprising berberine
AU2008251756B2 (en) * 2007-05-11 2013-06-06 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
US20100137449A1 (en) * 2007-12-10 2010-06-03 Metaproteomics, Llc Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
NZ587273A (en) * 2008-01-11 2013-04-26 United Paragon Associates Inc Fertilized egg isolate for treating depression and anxiety
US20100222262A1 (en) * 2008-04-02 2010-09-02 Metaproteomics, Llc Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
GB2471827B (en) * 2009-05-11 2013-11-20 Med Eq As Treatment of stress
CN102397294A (zh) * 2010-09-07 2012-04-04 丁庆 提取自受精卵的组合物的壮阳和强精功效及其制作方法
RO128485A0 (ro) 2012-09-19 2013-06-28 Hipocrate 2002 Serv S.R.L. Compoziţie cu biodisponibilitate crescută a embrio-peptidelor administrate oral şi procedeu de obţinere
WO2015160262A1 (en) * 2014-04-16 2015-10-22 Amerikal Nutraceutical Corp Anti-aging composition
NL2023582B1 (en) * 2019-07-29 2021-02-22 Hatchtech Group Bv Use of chicken embryo meat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1059230A (en) 1964-12-08 1967-02-15 Arthur Samy Improvements in or relating to therapeutic products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
ATE188609T1 (de) 2000-01-15
DE69327585D1 (de) 2000-02-17
CN1098625A (zh) 1995-02-15
JPH08502041A (ja) 1996-03-05
EP0656781A1 (en) 1995-06-14
EP0656781B1 (en) 2000-01-12
KR950702427A (ko) 1995-07-29
WO1994003192A1 (en) 1994-02-17
AU4715093A (en) 1994-03-03
US5641517A (en) 1997-06-24
JP3065353B2 (ja) 2000-07-17
CA2141197A1 (en) 1994-02-17
NZ254859A (en) 1997-02-24
FI950369L (fi) 1995-01-27
KR100277095B1 (ko) 2001-11-22
FI950369A7 (fi) 1995-01-27
CN1100545C (zh) 2003-02-05
DE69327585T2 (de) 2000-08-10
FI950369A0 (fi) 1995-01-27

Similar Documents

Publication Publication Date Title
IS4057A (is) Efni til að auka kyngetu
KR950702966A (ko) 성장 호르몬의 방출을 촉진시키는 벤조 융합된 락탐(Benzo-fused lactams promote release of growth hormone)
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
DE69024965D1 (de) Dehydrodidemnin b
ATE433324T1 (de) Verwendung von glp-1 oder analoge zur behandlung von schlaganfall
ES2131528T3 (es) Nuevos polipeptidos y su uso.
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69803773D1 (de) Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion
ATE179164T1 (de) Hiv-proteaseinhibitoren
MX9301789A (es) Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ES2175135T3 (es) Uso de galactanasa en piensos animales.
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
ES2162427T3 (es) Diluyente de esperma que comprende fosfocaseinato natural o beta-lactoglobulina, su procedimiento de preparacion y sus utilizaciones.
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
MX9201288A (es) Metodo de tratamiento.
ATE247649T1 (de) Disubstituierte biphenyloxazoline
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
DK0539451T3 (da) Vinylsulfonyl-pristinamycin og dets fremstilling
IL139898A0 (en) Anti-germ-attachment composition
TR199701227T1 (xx) Pestisidler.
KR970019821A (ko) 송진을 함유한 치약 제조 방법
KR890701118A (ko) 혈소판 감소증 예방 및 치료제